8.14
price down icon1.09%   -0.09
after-market アフターアワーズ: 8.14
loading
前日終値:
$8.23
開ける:
$8.2
24時間の取引高:
458.50K
Relative Volume:
0.92
時価総額:
$231.36M
収益:
$42.35M
当期純損益:
$-78.67M
株価収益率:
-2.8905
EPS:
-2.8161
ネットキャッシュフロー:
$-63.18M
1週間 パフォーマンス:
+15.46%
1か月 パフォーマンス:
+34.55%
6か月 パフォーマンス:
+10.00%
1年 パフォーマンス:
-58.21%
1日の値動き範囲:
Value
$7.96
$8.22
1週間の範囲:
Value
$7.06
$8.48
52週間の値動き範囲:
Value
$5.50
$24.17

Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile

Name
名前
Arcturus Therapeutics Holdings Inc
Name
セクター
Healthcare (1082)
Name
電話
(858) 900-2660
Name
住所
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Name
職員
111
Name
Twitter
@ArcturusRx
Name
次回の収益日
2026-08-10
Name
最新のSEC提出書
Name
ARCT's Discussions on Twitter

Compare ARCT vs VRTX, REGN, ARGX, RVMD, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ARCT icon
ARCT
Arcturus Therapeutics Holdings Inc
8.14 233.92M 42.35M -78.67M -63.18M -2.8161
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
515.55 128.19B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
805.93 82.72B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
987.84 53.26B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
212.00 43.66B 742.00K -1.37B -1.07B -7.0731
ONC icon
ONC
Beone Medicines Ltd Adr
362.51 39.31B 5.76B 514.49M 1.10B 4.4813

Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-18 開始されました B. Riley Securities Buy
2026-01-23 開始されました Roth Capital Buy
2025-10-24 ダウングレード H.C. Wainwright Buy → Neutral
2025-10-23 ダウングレード Citigroup Buy → Neutral
2025-10-22 ダウングレード Guggenheim Buy → Neutral
2025-09-04 再開されました H.C. Wainwright Buy
2025-05-28 開始されました Scotiabank Sector Outperform
2025-01-28 開始されました BTIG Research Buy
2024-08-12 開始されました Leerink Partners Outperform
2023-12-13 開始されました Canaccord Genuity Buy
2023-07-24 開始されました William Blair Outperform
2023-05-11 アップグレード H.C. Wainwright Neutral → Buy
2022-11-14 再開されました Wells Fargo Overweight
2022-11-10 ダウングレード Robert W. Baird Neutral → Underperform
2022-11-03 アップグレード Citigroup Neutral → Buy
2022-11-02 アップグレード Barclays Underweight → Equal Weight
2022-08-10 ダウングレード Raymond James Mkt Perform → Underperform
2022-07-19 再開されました Cantor Fitzgerald Overweight
2022-05-11 アップグレード Robert W. Baird Underperform → Neutral
2022-04-21 ダウングレード Citigroup Buy → Neutral
2022-01-31 アップグレード Raymond James Underperform → Mkt Perform
2021-08-12 ダウングレード Raymond James Mkt Perform → Underperform
2021-08-11 ダウングレード Goldman Neutral → Sell
2021-08-10 ダウングレード Robert W. Baird Neutral → Underperform
2021-07-02 開始されました Cantor Fitzgerald Overweight
2021-06-25 再開されました Goldman Neutral
2021-06-21 ダウングレード Barclays Equal Weight → Underweight
2021-06-04 再開されました Robert W. Baird Neutral
2021-02-17 ダウングレード B. Riley Securities Neutral → Sell
2021-01-19 ダウングレード B. Riley Securities Buy → Neutral
2021-01-15 ダウングレード B. Riley Securities Buy → Neutral
2021-01-07 開始されました Wells Fargo Overweight
2020-12-29 ダウングレード Barclays Overweight → Equal Weight
2020-12-29 ダウングレード H.C. Wainwright Buy → Neutral
2020-12-29 ダウングレード Raymond James Outperform → Mkt Perform
2020-12-29 ダウングレード Robert W. Baird Outperform → Neutral
2020-12-23 ダウングレード ROTH Capital Buy → Sell
2020-12-08 繰り返されました B. Riley Securities Buy
2020-12-07 繰り返されました B. Riley Securities Buy
2020-10-26 開始されました Barclays Overweight
2020-10-06 開始されました Citigroup Buy
2020-08-26 開始されました Piper Sandler Overweight
2020-07-30 再開されました ROTH Capital Buy
2020-07-16 開始されました Raymond James Outperform
2020-07-13 開始されました B. Riley FBR Buy
2020-06-09 ダウングレード WBB Securities Buy → Hold
2020-02-11 開始されました Robert W. Baird Outperform
2020-02-07 開始されました Guggenheim Buy
2020-02-06 開始されました Guggenheim Buy
2019-04-05 開始されました H.C. Wainwright Buy
2018-09-20 アップグレード WBB Securities Buy → Strong Buy
2018-01-22 開始されました Chardan Capital Markets Buy
すべてを表示

Arcturus Therapeutics Holdings Inc (ARCT) 最新ニュース

pulisher
04:34 AM

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

04:34 AM
pulisher
Aug 16, 2026

Liquidity Mapping Around (ARCT) Price Events - Stock Traders Daily

Aug 16, 2026
pulisher
Aug 14, 2026

We're Keeping An Eye On Arcturus Therapeutics Holdings' (NASDAQ:ARCT) Cash Burn Rate - Moomoo

Aug 14, 2026
pulisher
Aug 14, 2026

Dimensional Fund Advisors LP Decreases Holdings in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat

Aug 14, 2026
pulisher
Aug 13, 2026

HC Wainwright Has Optimistic Outlook of ARCT Q3 Earnings - marketbeat.com

Aug 13, 2026
pulisher
Aug 11, 2026

Arcturus Therapeutics Eyes Phase III CF Call, OTC Data as Vaccine Funds Pipeline - marketbeat.com

Aug 11, 2026
pulisher
Aug 11, 2026

H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Hold Rating, Maintains Target Price $9 - Moomoo

Aug 11, 2026
pulisher
Aug 10, 2026

BTIG Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $23 - Moomoo

Aug 10, 2026
pulisher
Aug 09, 2026

Arcturus Therapeutics (NASDAQ:ARCT) Rating Increased to Sell at Wall Street Zen - MarketBeat

Aug 09, 2026
pulisher
Aug 07, 2026

Arcturus Therapeutics (NASDAQ:ARCT) Announces Earnings Results, Beats Estimates By $0.16 EPS - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

A Quick Look at Today's Ratings for Arcturus Therapeutics(ARCT.US), With a Forecast Between $20 to $20 - Moomoo

Aug 07, 2026
pulisher
Aug 07, 2026

Arcturus Therapeutics Holdings Inc. Stock 12‑Month Price Target Cut to $20.2, Implies 232% Upside - TradingView

Aug 07, 2026
pulisher
Aug 07, 2026

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Cuts Target Price to $20 - Moomoo

Aug 07, 2026
pulisher
Aug 07, 2026

Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress - BioSpace

Aug 07, 2026
pulisher
Aug 07, 2026

ARCT Looks 57.9% Overvalued on GF Value™ - GuruFocus

Aug 07, 2026
pulisher
Aug 06, 2026

Earnings call transcript: Arcturus Therapeutics tops Q2 2026 EPS view By Investing.com - Investing.com South Africa

Aug 06, 2026
pulisher
Aug 06, 2026

Arcturus Therapeutics Q2 Earnings Call Highlights - MarketBeat

Aug 06, 2026
pulisher
Aug 06, 2026

Earnings call transcript: Arcturus Therapeutics tops Q2 2026 EPS view - Investing.com

Aug 06, 2026
pulisher
Aug 06, 2026

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Aug 06, 2026
pulisher
Aug 06, 2026

Arcturus Therapeutics Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Arcturus Therapeutics Holdings Inc. Q2 2026: Revenue $2.96M, EPS $(0.84) — 10-Q Summary - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Q2 2026 Arcturus Therapeutics Holdings Inc Earnings Call Transcript - GuruFocus

Aug 06, 2026
pulisher
Aug 06, 2026

Arcturus Therapeutics | 10-Q: Q2 2026 Earnings Report - Moomoo

Aug 06, 2026
pulisher
Aug 06, 2026

Arcturus Therapeutics Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 06, 2026
pulisher
Aug 06, 2026

Arcturus Therapeutics reports Q2 2026: $3.0M revenue, $23.8M net loss, $191.5M cash - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Arcturus Therapeutics: Q2 Earnings Snapshot - marketscreener.com

Aug 06, 2026
pulisher
Aug 05, 2026

Why (ARCT) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Aug 05, 2026
pulisher
Aug 05, 2026

Earnings To Watch: Arcturus Therapeutics Holdings Inc (ARCT) Q2 2026 -- GF Value Sees 44% Downside - Yahoo Finance

Aug 05, 2026
pulisher
Aug 04, 2026

Arcturus Therapeutics Holdings Inc expected to post a loss of 100 cents a shareEarnings Preview - TradingView

Aug 04, 2026
pulisher
Aug 01, 2026

Arcturus Therapeutics (NASDAQ:ARCT) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat

Aug 01, 2026
pulisher
Jul 31, 2026

Arcturus Therapeutics (ARCT) to Announce Quarterly Earnings on Thursday - MarketBeat

Jul 31, 2026
pulisher
Jul 29, 2026

Arcturus Therapeutics Q2 Results: Financials and update due Aug 6 - scanx.trade

Jul 29, 2026
pulisher
Jul 28, 2026

Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026 - Yahoo Finance

Jul 28, 2026
pulisher
Jul 27, 2026

Arcturus Therapeutics Holdings Inc - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

Arcturus Therapeutics Holdings Inc (ARCT) Cash Flow - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Arcturus Therapeutics Holdings Inc (ARCT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Arcturus Therapeutics Holdings Inc (ARCT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

Arcturus Therapeutics Holdings Inc (ARCT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 25, 2026
pulisher
Jul 24, 2026

Arcturus Therapeutics Holdings Inc. (ARCT) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com

Jul 24, 2026
pulisher
Jul 24, 2026

ARCT|Arcturus Therapeutics Holdings Inc|Price:5.530|Chg%:-0.260 - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Arcturus Therapeutics Holdings Inc. Revenue Breakdown – NASDAQ:ARCT - TradingView

Jul 24, 2026
pulisher
Jul 23, 2026

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Jul 23, 2026
pulisher
Jul 21, 2026

Arcturus Therapeutics Holdings Inc (ARCT) Earnings, Actual EPS, EPS Estimates & Results - Stocktwits

Jul 21, 2026
pulisher
Jul 21, 2026

Amova Asset Management Americas Inc. Grows Stock Holdings in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat

Jul 21, 2026
pulisher
Jul 20, 2026

Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference - BioSpace

Jul 20, 2026
pulisher
Jul 20, 2026

Arcturus: Now That It's Come This Low, It's Time To Buy And Hold (NASDAQ:ARCT) - Seeking Alpha

Jul 20, 2026
pulisher
Jul 18, 2026

Arcturus Therapeutics (ARCT) Q1 2026 Earnings: Loss Narrows as Pipeline Progress Offsets Revenue Absence - dars.gov.et

Jul 18, 2026
pulisher
Jul 16, 2026

Arcturus Therapeutics Holdings Inc (ARCT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 16, 2026
pulisher
Jul 15, 2026

Roth MKM Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $20 - Moomoo

Jul 15, 2026
pulisher
Jul 13, 2026

Understanding Momentum Shifts in (ARCT) - Stock Traders Daily

Jul 13, 2026
pulisher
Jul 11, 2026

Is Arcturus Therapeutics' ARCT-032 a Game Changer for Cystic Fibrosis - Kavout | AI

Jul 11, 2026

Arcturus Therapeutics Holdings Inc (ARCT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$64.46
price up icon 1.80%
$36.24
price up icon 0.11%
$59.45
price up icon 1.45%
$128.32
price up icon 3.70%
$224.60
price down icon 1.77%
ONC ONC
$362.51
price up icon 4.33%
大文字化:     |  ボリューム (24 時間):